| 1 |
34198150 | Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine. | 2021 Nov 5 |
2 |
| 2 |
27785538 | Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV. | 2017 Mar |
1 |
| 3 |
26280153 | Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. | 2015 Nov |
1 |
| 4 |
22596267 | [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis. | 2012 |
1 |
| 5 |
19380700 | Age-associated leukoaraiosis and cortical cholinergic deafferentation. | 2009 Apr 21 |
1 |
| 6 |
18155915 | Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes. | 2008 Apr |
1 |
| 7 |
18210807 | [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders]. | 2007 Nov |
2 |
| 8 |
16631094 | Quality control of PET radiopharmaceuticals using HPLC with electrochemical detection. | 2006 Apr |
1 |
| 9 |
15134572 | Acetylcholinesterase imaging: its use in therapy evaluation and drug design. | 2004 |
4 |
| 10 |
12112408 | PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor. | 2002 Jul |
1 |
| 11 |
11176277 | Quantitative measurement of cerebral acetylcholinesterase using. | 2001 Feb |
1 |
| 12 |
11295884 | Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease. | 2001 Mar |
1 |
| 13 |
10939570 | Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. | 2000 Aug |
1 |
| 14 |
10377794 | [PET study of cholinergic system in the brain]. | 1999 Jan |
2 |
| 15 |
9863562 | Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. | 1998 Nov |
1 |
| 16 |
9863564 | Syntheses of carbon-11 labeled piperidine esters as potential in vivo substrates for acetylcholinesterase. | 1998 Nov |
3 |
| 17 |
8764619 | In vivo imaging of human cerebral acetylcholinesterase. | 1996 Aug |
6 |
| 18 |
8787128 | In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). | 1996 Feb |
2 |